Navigation Links
Norgen Biotek Transitions into Diagnostics with the Launch of over 30 New Kits for Nucleic Acid-Based Diagnostics

THOROLD, ON, March 18 /PRNewswire/ - Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of over 30 new kits for nucleic-acid based diagnostics. Norgen makes best-in-class kits for nucleic acid and protein sample preparation, and has recognized that high quality sample preparation is the key to high quality diagnostics. Norgen's new basket of diagnostic kits includes kits for the diagnosis of human pathogens such as: HPV, HIV, HCV-1 & 2, HBV, Chlamydia, Gonorrhea; food-borne pathogens such as: Listeria, Salmonella, Streptococcus species, etc and plant pathogens such as: Plum Pox Virus (PPV), Aspergillus, Penicillium, Boytritis, etc. In terms of diagnostic kits for the human pathogens, particular attention has been paid to the development of kits based on non-invasive sample preparation. Non-invasive sample collection offers a number of distinct benefits for diagnostics, and therefore the first kits which Norgen plans to obtain regulatory approval for are the urine-based pathogen detection kits. For a more comprehensive list of the newly launched kits, please visit

Norgen's diagnostic kits are complete kits that include all the components for the isolation of high quality inhibitor-free nucleic acids, as well as the required master mixes and controls to allow for PCR amplification and detection. The kits combine both sensitivity and specificity of detection, and include controls to eliminate false negatives and problematic isolations. Initially, these kits are for research use only and are ideal for use in surveillance of drug resistant pathogens, epidemiological studies, field surveillance of pathogens, and surveys.

"The transition of our powerful nucleic acid isolation technology into diagnostics is a natural extension for us. The quality of a diagnostic kit is only as good as the quality of the sample, and as leaders in sample preparation we are in an ideal position to make this transition." said Dr. Haj-Ahmad, President & CEO of Norgen Biotek. "We make best-in-class kits for the isolation of high quality RNA, DNA and proteins from urine, and therefore we extended our expertise and developed our new line of urine-based diagnostic kits for the detection of human pathogens that are traditionally detected in blood or plasma. These kits will become invaluable tools for non-invasive urine-based diagnostics" added Dr. Haj-Ahmad

About Norgen Biotek Corp.


Norgen Biotek, an ISO 13485:2003 and ISO 9001:2008 registered company, is a rapidly growing privately-held Canadian biotech company committed to providing innovative products and services to the life sciences and pharmaceutical industry. Norgen has developed technologies and products for the purification of nucleic acids and proteins on both preparative and industrial scales, including ready-to-use chromatography resins and pre-packed chromatography columns. Norgen is seeking partners to conduct clinical testing and obtain regulatory approvals for their new line of non-invasive diagnostic kits, as well as other modalities of business opportunities.

SOURCE Norgen Biotek Corp.

Back to top
SOURCE Norgen Biotek Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Norgen Biotek Corp. Launches Four New Kits for the Purification of RNA and DNA from Plants and Fungi
2. Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S
3. Norgen Biotek Launches 10 New Kits for the Isolation of High-Quality Circulating Nucleic Acids from Blood, Plasma and Serum
4. Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care
5. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
6. Strategic Diagnostics Updates Roth Conference Presentation Time
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
9. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
10. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference
11. BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards
Post Your Comments:
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... ... 2016 , ... UAS LifeSciences, one of the leading manufacturers ... Probiotics, into Target stores nationwide. The company, which has been manufacturing high quality ... list of well-respected retailers. This list includes such fine stores as Whole Foods, ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology:
(Date:6/9/2016)... June 9, 2016 Paris ... Teleste,s video security solution to ensure the safety of people ... during the major tournament Teleste, an international ... and services, announced today that its video security solution will ... to back up public safety across the country. The system ...
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
(Date:5/12/2016)... May 12, 2016 , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
Breaking Biology News(10 mins):